Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) were down 5.3% on Friday . The stock traded as low as $15.52 and last traded at $15.59. Approximately 965,829 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 2,905,068 shares. The stock had previously closed at $16.47. Analyst […]
Should You Buy or Sell BridgeBio Pharma Stock? Get The Latest BBIO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $15.15, but opened at $16.19. BridgeBio Pharma shares last traded at $15.78, with a volume of 355,107 shares trading hands. Analysts Set New Price Targets A number of equities research analysts have […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up before the market opened on Thursday after SVB Securities raised their price target on the stock from $25.00 to $27.00. The stock had previously closed at $15.18, but opened at $15.58. BridgeBio Pharma shares last traded at $15.87, with a volume of 112,369 shares. […]
BridgeBio Pharma (NASDAQ:BBIO – Get Rating) had its price target hoisted by analysts at SVB Securities from $25.00 to $27.00 in a research note issued on Thursday, The Fly reports. SVB Securities’ target price points to a potential upside of 77.87% from the stock’s current price. Several other equities research analysts also recently commented on […]